Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:54:36 EDT Tue 10 Mar 2026
Enter Symbol
or Name
USA
CA



Forgot password?
Trouble logging in?
Login ID:
Password:
Save

T:MDP - MEDEXUS PHARMACEUTICALS INC. J - https://www.medexus.ca/
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
MDP - T  0.43.23·3.292.03.25+0.154.852.11621883.09  3.335  3.093.61  1.9614:28:30Feb 1115 min RT 2¢
TSX - T0.43.23·3.292.03.25+0.154.833.2105733.10  3.335  3.103.61  1.9614:28:3015 min
NEO ATS - U 3.25+0.154.82.27283.23  3.30  3.2214:28:3015 min
Alpha - A 3.29+0.196.10.5233.22  3.29  3.2214:18:5115 min
Omega - O 3.15+0.051.60.5213.15  3.15  3.1509:47:3315 min
CSE ATS - P 3.28+0.185.83.511133.09  3.30  3.0914:21:4615 min
CXC - X 3.25+0.154.80.5233.23  3.29  3.2314:28:3015 min
CX2 - H 3.25+0.154.80.9343.21  3.25  3.2113:11:2115 min
CXD - D 3.285+0.1856.00.5253.24  3.285  3.23514:24:2215 min
MatchNOW - M 3.105.51644    Sep 11-2015 min
Lynx - Y 3.29+0.196.14.815133.25  3.29  3.2214:18:5115 min
CS2 - S 3.100.031    Oct 1015 min

Recent Trades - Last 10 of 188
Time ETExPriceChangeVolumeBuyerSellerMarkers
14:28:30T3.250.151001 Anonymous14 Virtu ITGK
14:28:30U3.250.1510079 CIBC14 Virtu ITGK
14:28:30X3.250.1520039 Merrill Lynch14 Virtu ITGK
14:28:30T3.250.1510079 CIBC14 Virtu ITGK
14:28:30U3.250.1510079 CIBC14 Virtu ITGK
14:27:18U3.270.1710079 CIBC14 Virtu ITGK
14:27:18T3.270.1730079 CIBC14 Virtu ITGK
14:27:18U3.270.1710079 CIBC14 Virtu ITGK
14:24:22D3.2850.1851001 Anonymous79 CIBCK
14:24:22X3.290.192001 Anonymous1 AnonymousK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2026-02-11 17:42C:MDP2.81SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2026-02-11 17:42C:MDP2.81SEDAR Interim MD & ASEDAR Interim MD & A
2026-02-11 17:31C:MDP2.81News ReleaseMedexus Announces Fiscal Q3 2026 Results, Driven by Continued Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
2026-02-03 17:31C:MDP2.89News ReleaseMedexus Schedules Third Fiscal Quarter 2026 Conference Call
2025-11-20 16:39C:MDP2.61News ReleaseMedexus arranges NCIB to buy back up to 10% of float
2025-11-17 18:35C:MDP2.70News ReleaseMedexus obtains $51-million (U.S.) credit, plans NCIB
2025-11-12 18:18C:MDP2.70SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-11-12 18:18C:MDP2.70SEDAR Interim MD & ASEDAR Interim MD & A
2025-11-12 18:07C:MDP2.70News ReleaseMedexus Announces Fiscal Q2 2026 Results, Driven by Strong Year-To-Date Product-Level Performance of GRAFAPEX (treosulfan) for Injection
2025-11-05 00:49C:MDP2.69News ReleaseMedexus Pharmaceuticals to release Q2 results Nov. 12
2025-09-26 04:40C:MDP2.97News ReleaseMedexus shareholders approve all proposals at AGM
2025-08-12 17:44C:MDP2.75SEDAR Interim MD & ASEDAR Interim MD & A
2025-08-12 17:38C:MDP2.75SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-08-12 17:30C:MDP2.75News ReleaseMedexus Announces Fiscal Q1 2026 Results, Including Positive Results from US Launch of GRAFAPEX (treosulfan) for Injection
2025-08-05 17:31C:MDP2.89News ReleaseMedexus Schedules First Fiscal Quarter 2026 Conference Call
2025-08-05 17:30C:MDP2.89News ReleaseMedexus's Grafapex add-on payment okayed by Medicare
2025-06-25 18:40C:MDP3.35SEDAR Annual Information FormSEDAR Annual Information Form
2025-06-25 18:40C:MDP3.35SEDAR MD & ASEDAR MD & A
2025-06-25 18:29C:MDP3.35SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-06-25 18:16C:MDP3.35News ReleaseMedexus Announces Strong Fiscal Year 2025 Results, Including Initial Results from Launch of GRAFAPEX (treosulfan) for Injection in the United States